HLAVATÁ, Pavlína, Pavla LINHARTOVÁ, Rastislav ŠUMEC, Pavel FILIP, Miroslav SVĚTLÁK, Marek BALÁŽ, Tomáš KAŠPÁREK a Martin BAREŠ. Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease. Online. FRONTIERS IN NEUROLOGY. LAUSANNE: FRONTIERS MEDIA SA, 2020, roč. 10, JAN 10 2020, s. 1-12. ISSN 1664-2295. Dostupné z: https://dx.doi.org/10.3389/fneur.2019.01338. [citováno 2024-04-23]
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Behavioral and Neuroanatomical Account of Impulsivity in Parkinson's Disease
Autoři HLAVATÁ, Pavlína (203 Česká republika, domácí), Pavla LINHARTOVÁ (203 Česká republika, domácí), Rastislav ŠUMEC (703 Slovensko, domácí), Pavel FILIP (703 Slovensko, garant, domácí), Miroslav SVĚTLÁK (203 Česká republika, domácí), Marek BALÁŽ (703 Slovensko, domácí), Tomáš KAŠPÁREK (203 Česká republika, domácí) a Martin BAREŠ (203 Česká republika, domácí)
Vydání FRONTIERS IN NEUROLOGY, LAUSANNE, FRONTIERS MEDIA SA, 2020, 1664-2295.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.003
Kód RIV RIV/00216224:14110/20:00115338
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3389/fneur.2019.01338
UT WoS 000509278800001
Klíčová slova anglicky impulse control disorder; Parkinson's disease; impulsive action; impulsive choice; structural MRI; Iowa gambling task; delay discounting task; stop signal task
Štítky 14110127, 14110222, 14110523, CF MAFIL, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Pavla Foltynová, Ph.D., učo 106624. Změněno: 22. 2. 2021 12:19.
Anotace
Impulse control disorder (ICD) is a major non-motor complication of Parkinson's disease (PD) with often devastating consequences for patients' quality of life. In this study, we aimed to characterize the phenotype of impulsivity in PD and its neuroanatomical correlates. Methods: Thirty-seven PD patients (15 patients with ICD, 22 patients without ICD) and 36 healthy controls underwent a neuropsychological battery. The test battery consisted of anxiety and depression scales, self-report measures of impulsivity (Barratt scale and UPPS-P), behavioral measures of impulsive action (Go/No-Go task, Stop signal task) and impulsive choice (Delay discounting, Iowa gambling task), and measures of cognitive abilities (working memory, attention, executive function). Patients and controls underwent structural MRI scanning. Results: Patients with ICD had significantly higher levels of self-reported impulsivity (Barratt scale and Lack of perseverance from UPPS-P) in comparison with healthy controls and non-impulsive PD patients, but they performed similarly in behavioral tasks, except for the Iowa gambling task. In this task, patients with ICD made significantly less risky decisions than patients without ICD and healthy controls. Patients without ICD did not differ from healthy controls in self-reported impulsivity or behavioral measurements. Both patient groups were more anxious and depressive than healthy controls. MRI scanning revealed structural differences in cortical areas related to impulse control in both patient groups. Patients without ICD had lower volumes and cortical thickness of bilateral inferior frontal gyrus. Patients with ICD had higher volumes of right caudal anterior cingulate and rostral middle frontal cortex. Conclusions: Despite the presence of ICD as confirmed by both clinical follow-up and self-reported impulsivity scales and supported by structural differences in various neural nodes related to inhibitory control and reward processing, patients with ICD performed no worse than healthy controls in various behavioral tasks previously hypothesized as robust impulsivity measures. These results call for caution against impetuous interpretation of behavioral tests, since various factors may and will influence the ultimate outcomes, be it the lack of sensitivity in specific, limited ICD subtypes, excessive caution of ICD patients during testing due to previous negative experience rendering simplistic tasks insufficient, or other, as of now unknown aspects, calling for further research.
Návaznosti
LM2015062, projekt VaVNázev: Národní infrastruktura pro biologické a medicínské zobrazování
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, National research infrastructure for biological and medical imaging
NV15-30062A, projekt VaVNázev: Fenotypy impulzivity u neuropsychiatrických poruch a jejich klinický význam
691110, interní kód MUNázev: Advanced MR methods for characterization of microstructural brain damage (MICROBRADAM) (Akronym: MICROBRADAM)
Investor: Evropská unie, Advanced MR methods for characterization of microstructural brain damage (MICROBRADAM), MSCA Marie Skłodowska-Curie Actions (Excellent Science)
VytisknoutZobrazeno: 23. 4. 2024 23:36